Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3. This indicates a newer release of the page template or rendering tooling used to present the study record.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment status updated to no longer recruit; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was standardized, and the page revision tag was updated to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedPage revision changed from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata. This update does not alter the study content or user-facing functionality.SummaryDifference0.0%

- Check57 days agoChange DetectedThe revision tag on the page updated from v3.5.3 to v3.5.4, signaling a minor backend update to the page. The visible content and user-facing information remain unchanged.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page’s site revision label updated from **v3.5.2** to **v3.5.3** at the bottom of the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.